Why Translate Bio Stock Soared Today
Shares of Translate Bio (NASDAQ: TBIO) surged 29% on Tuesday after the U.S. biotechnology company said it agreed to be acquired by French pharmaceutical giant Sanofi (NASDAQ: SNY).
The all-cash deal values Translate Bio at roughly $3.2 billion, or $38 per share. That represents a premium of more than 30% above the stock's closing price on Monday. The transaction is expected to close in the third quarter, subject to regulatory and shareholder approval.
Image source: Getty Images.
Source Fool.com


